Literature DB >> 15743693

Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance.

Masami Shibata1, Isamu Kodani, Mitsuhiko Osaki, Kunio Araki, Hironobu Adachi, Kazuo Ryoke, Hisao Ito.   

Abstract

Cyclo-oxygenase (COX) is a key enzyme in the conversion of arachidonic acid to prostanoids. The expression of its isoforms, COX-1 and -2 is found in many human malignancies. This study analyzed the correlation between COX expression and the pathobiological nature of human oral mucosa, dysplasias and squamous cell carcinomas (SCCs). We examined 9 specimens of normal oral epithelia, 65 lesions with dysplasias and 50 SCCs. Labeling indices (LIs) for COX-1, COX-2, Ki-67 and P53, microvessel density (MVD) and apoptotic index (AI) were evaluated using immunohistochemistry and TUNEL methods. Western blot analysis of COX-1 and -2 was performed on four human oral SCC cell lines, all of which showed expression. The LIs for COX-1 and -2 were higher for the dysplasias than the SCCs. LIs of COX-2 but not COX-1 correlated with the histological grade of dysplasia, being highest for the severe dysplasias (p < 0.05). In contrast, the COX-2 LIs as well as COX-1 were significantly (p < 0.05) inversely correlated with the histological differentiation of the SCCs. COX-2 expression was significantly correlated with LIs of COX-1 for dysplasia (p < 0.05), but not for the SCCs. In addition no significant relationship was noted between COX-2 expression and the Lis of Ki-67, P53, AI as well as MVD for the dysplasias and SCCs. The expression of COX-1 and -2 is correlated with early stage tumorigenesis and cellular differentiation of SCCs in the oral dysplasia-carcinoma sequence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743693     DOI: 10.1016/j.oraloncology.2004.09.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  Low-level laser therapy modulates cyclo-oxygenase-2 expression during bone repair in rats.

Authors:  Mariza A Matsumoto; Rafael V Ferino; Giovanni F Monteleone; Daniel A Ribeiro
Journal:  Lasers Med Sci       Date:  2008-02-29       Impact factor: 3.161

2.  Circulating cycloxygenase-2 in patients with tobacco-related intraoral squamous cell carcinoma and evaluation of its peptide inhibitors as potential antitumor agent.

Authors:  Vaishali Kapoor; Abhay K Singh; Sharmistha Dey; Suresh C Sharma; Satya N Das
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

3.  Expression of cyclooxygenase-2, peroxiredoxin I, peroxiredoxin 6 and nuclear factor-κB in oral squamous cell carcinoma.

Authors:  Eun-Young Lee; Ji-Yeon Kang; Kyoung-Won Kim
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

4.  Odontogenic epithelial proliferation is correlated with COX-2 expression in dentigerous cyst and ameloblastoma.

Authors:  Mohammed Amjed Alsaegh; Hitoshi Miyashita; Takahiro Taniguchi; Sheng Rong Zhu
Journal:  Exp Ther Med       Date:  2016-12-01       Impact factor: 2.447

5.  Zyflamend reduces LTB4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[alpha]anthracene (DMBA)-induced hamster cheek pouch model.

Authors:  Peiying Yang; Zheng Sun; Diana Chan; Carrie A Cartwright; Mary Vijjeswarapu; Jibin Ding; Xiaoxin Chen; Robert A Newman
Journal:  Carcinogenesis       Date:  2008-08-06       Impact factor: 4.944

6.  Altered lipid parameters in hepatic subcellular membrane fractions induced by fumonisin B1.

Authors:  H-M Burger; S Abel; P W Snijman; S Swanevelder; W C A Gelderblom
Journal:  Lipids       Date:  2007-02-09       Impact factor: 1.880

7.  Role of cyclooxygenase-2 in tumor progression and survival of head and neck squamous cell carcinoma.

Authors:  Nabil F Saba; Misun Choi; Susan Muller; Hyung Ju C Shin; Mourad Tighiouart; Vassiliki A Papadimitrakopoulou; Adel K El-Naggar; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-08

8.  COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure.

Authors:  Reetta Holmila; Diane Cyr; Danièle Luce; Pirjo Heikkilä; Michael Dictor; Torben Steiniche; Tuula Stjernvall; Jette Bornholdt; Håkan Wallin; Henrik Wolff; Kirsti Husgafvel-Pursiainen
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

9.  Expression of Ki-67, p53, α-SMA and COX-2 in lichen planus and related lesions: A pilot study.

Authors:  D S Sanketh; Karuna Kumari; Roopa S Rao; Vanishree C Haragannavar; Sachin C Sarode; Gargi S Sarode; A Thirumal Raj; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2018-02-19

10.  Feasibility of recruitment to an oral dysplasia trial in the United Kingdom.

Authors:  Paul Nankivell; Janet Dunn; Michael Langman; Hisham Mehanna
Journal:  Head Neck Oncol       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.